Background and Purpose: Carotid and vertebral artery dissections are frequently complicated by cerebral embolism. Detection of clinically silent circulating microemboli by transcranial Doppler sonography (TCD) is now widely investigated in patients with carotid artery disease in the hope to identify patients at increased risk for stroke. Methods: In 20 patients with carotid (n = 17) or vertebral (n = 2) artery dissection, or both (n = 1), we performed a 1-hour microembolus detection downstream to the dissection in the middle or in the posterior cerebral artery, respectively. Results: Five patients with a carotid artery stenosis of ≧90% or with carotid artery occlusion showed microembolic signals at a rate of up to 15 events/h. In all these patients, the onset of the dissection was within the last 58 days. Patients with lower degrees of stenosis or onset of symptoms beyond 58 days did not show microembolic signals at all. Three patients who had presented with recurrent ischaemic events prior to TCD monitoring unexceptionally had microembolic signals. Conclusion: Microembolic signals occur in patients with high-grade stenosis or occlusion due to acute cervical artery dissection. Patients with microemboli seem to be at increased macroembolic risk, i.e. stroke recurrence, and may require close-meshed clinical follow-up and possibly stronger antithrombotic treatment.

Keywords:
Ultrasonography, Cerebral blood flow, Embolism, Dissection
1.
Huang ZS, Teng CM, Lee TK, Shun CT, Wang CY: Combined use of aspirin and heparin inhibits in vivo acute carotid thrombosis. Stroke 1993;24:829–836.
2.
Guillon B, Levy C, Bousser MG: Internal carotid artery dissection: An update. J Neurol Sci 1998;153:146–158.
3.
Lucas C, Moulin T, Deplanque D, Tatu L, Chavot D: Stroke patterns of internal carotid artery dissection in 40 patients. Stroke 1998;29:2646–2648.
4.
Barinagarrementeria F, Amaya LE, Cantu C: Causes and mechanisms of cerebellar infarction in young patients. Stroke 1997;28:2400–2404.
5.
Caplan LR, Tettenborn B: Vertebrobasilar occlusive disease: Review of selected aspects. Cerebrovasc Dis 1992;2:266–272.
6.
Spencer MP, Thomas GI, Nicholls SC, Sauvage LR: Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke 1990;21:415–423.
7.
Spencer MP: Detection of cerebral arterial emboli; in Newell DW, Aaslid R (eds): Transcranial Doppler. New York, Raven Press, 1992, pp 216–230.
8.
Koennecke HC, Trocio SH Jr, Mast H, Mohr JP: Microemboli on transcranial Doppler in patients with spontaneous carotid artery dissection. J Neuroimaging 1997;7:217–220.
9.
Babikian VL, Forteza AM, Gavrilescu T, Samaraweera R: Cerebral microembolism and extracranial internal carotid artery dissection. J Ultrasound Med 1996;15:863–866.
10.
Srinivasan J, Newell DW, Sturzenegger M, Mayberg MR, Winn HR: Transcranial Doppler in the evaluation of internal carotid artery dissection. Stroke 1996;27:1226–1230.
11.
Droste DW, Markus HS, Brown MM: The effect of different settings of ultrasound pulse amplitude, gain and sample volume on the appearance of emboli studied in a transcranial Doppler model. Cerebrovasc Dis 1994;4:152–156.
12.
Droste DW, Ringelstein EB: Detection of high intensity transient signals (HITS): How and why? Eur J Ultrasound 1998;7:23–29.
13.
Consensus Committee of the 9th International Cerebral Hemodynamics Symposium: Basic identification criteria of Doppler microembolic signals. Stroke 1995;26:1123.
14.
Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, Markus HS, Russell D, Siebler M: Consensus on microembolus detection by transcranial Doppler ultrasound. Stroke 1998;29:725–729.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.